Trial intelligence / Profile preview

Sisomicin Cream vs Nadifloxacin Cream in Primary Pyodermas

NCT00202891Phase 4Withdrawn

Sponsor
Merck & Co.
Start
May 2007
Modality
Small Molecules
01

Overview

A Phase 4 trial of sisomicin in Pyoderma, sponsored by Merck & Co.. Planned start May 2007; status: withdrawn.

02

Drugs

sisomicin
03

Conditions

Pyoderma

Beyond the preview

Go deeper on NCT00202891.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00202891.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call